Kawasaki disease. Report of a rare case in an adult

Kawasaki disease in Colombia: A systematic review and contrast with multisystem inflammatory syndrome in children associated with COVID-19

“…Table 1 summarizes the main features of these studies. [22][23][24][25][26][27][28][29][30][31][32][33][34][35][36][37][38]…”

“…The majority of these (88, i.e., 90.7%) had a good clinical response, with resolution of fever and amelioration or full disappearance of the other complaints. IVIG resistance, defined 28 1 30 1 31 1 0 1 M: 1 I: 1 1 1 1 1 0 0 1 0 Jaramillo et al 32 4 as persistence or recrudescence of fever at least 36 h after the completion of the IVIG infusion, 8 was observed in 6 patients (6.2%). On the other hand, 3 of them (3.1%) presented a relapse of the disease after 48 h of defervescence.…”

“…80 Therefore, the diagnosis of KD in adults is exceedingly rare, and very few cases have been reported worldwide. 30 Furthermore, this condition is more frequent among male individuals, with a male to female ratio around 1.5-1. 2 Consistent with these data, in the patients included in this study, 90.4% were aged 5 years or less, and most of them were male, with a male to female ratio of 1.6-1.…”

“…However, in the articles reviewed, a case of a 36-years-old adult diagnosed with KD was reported. 30 There are two main sets of diagnostic criteria used for KD, proposed by the AHA and the JCS separately. 8,39 Despite being very similar to each other, the main difference between them is the fever being or not a requisite for the diagnosis.…”